This site is intended for healthcare professionals only
Sign InRegister
AstraZeneca launches clinical data, insights division in IndiaAstraZeneca launches clinical data, insights division in India
42 drug samples fail to qualify CDSCO test, 1 declared misbranded42 drug samples fail to qualify CDSCO test, 1 declared misbranded
Gilead Biktarvy expanded indication for HIV-1 treatment in pediatrics gets USFDA okayGilead Biktarvy expanded indication for HIV-1 treatment in pediatrics gets USFDA okay
Dr Reddys, MSN Labs launch of generic Empagliflozin may lead to court battleDr Reddys, MSN Labs launch of generic Empagliflozin may lead to court battle
JnJ keeps vaccine sales outlook unchanged after Q3 missJnJ keeps vaccine sales outlook unchanged after Q3 miss
USFDA panel mulls mixing, matching Covid-19 vaccine dosesUSFDA panel mulls mixing, matching Covid-19 vaccine doses
ITAT larger bench to decide on the fate of pharma freebies to doctorsITAT larger bench to decide on the fate of pharma freebies to doctors
Potential presence of carcinogen: Lupin recalls Irbesartan, Irbesartan & Hydrochlorothiazide tabletsPotential presence of carcinogen: Lupin recalls Irbesartan, Irbesartan & Hydrochlorothiazide tablets
Oyster Point Pharma secures USFDA approval for TYRVAYA nasal spray to treat dry eye diseaseOyster Point Pharma secures USFDA approval for TYRVAYA nasal spray to treat dry eye disease
Dr Reddys Labs bags USFDA okay for Lenalidomide capsulesDr Reddy's Labs bags USFDA okay for Lenalidomide capsules
Granules India arm gets USFDA nod for Dofetilide capsulesGranules India arm gets USFDA nod for Dofetilide capsules
WHO-led program aims to purchase antiviral COVID pills for USD 10WHO-led program aims to purchase antiviral COVID pills for USD 10
X
Advertisement
X
X